From the Guardian
EU’s joint approach may have secured lower prices and guarantees, but it came at the expense of speed – and at such a critical moment, it can only watch as the UK, which paid the full price, is benefiting from its early orders.
However, the EU approach came with strings. The commission, negotiating for the first time on vital medicines, felt that EU countries would demand value for money, so it dragged out the talks to secure better prices and product liability guarantees. That meant it signed the contracts with AstraZeneca in August, three months after the UK’s contract
Seems like the EU were driven by money (Greed) the Astrazeneca vaccine was sold at cost to the world but the EU wanted to get it even cheaper.
Gransnet forums
Chat
Join the conversation
Registering is free, easy, and means you can join the discussion, watch threads and lots more.
Register now »Already registered? Log in with:
Gransnet »

